Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Sandu Pharmaceuticals Management Change

Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.

Source

BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sandu Pharmaceuticals Ltd: key numbers

Share price
₹35.31
Market cap
₹34.11 Cr
Revenue (annual)
₹69.93 Cr
Net profit (annual)
₹1.77 Cr
P/E (TTM)
14.0×Sector 48.7×
Promoter holding
37.79%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sandu Pharmaceuticals Ltd

All →

Other management change announcements

All →